close
Medical products

Utah Medical Products, Inc. Declares Quarterly Dividend of $0.29 (NASDAQ: UTMD)


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) declared a quarterly dividend on Tuesday, May 10, Zacks reports. Shareholders of record on Friday, June 17 will receive a dividend of 0.29 per share from the medical device supplier on Wednesday, July 6. This represents a dividend of $1.16 on an annualized basis and a yield of 1.37%. The ex-dividend date is Thursday, June 16.

Utah Medical Products has increased its dividend payout by an average of 38.1% per year over the past three years and has increased its dividend each year for the past 1 consecutive years.

NASDAQ UTMD traded down $0.06 during Wednesday’s trading, hitting $84.66. The stock had a trading volume of 9 shares, compared to an average volume of 13,666 shares. The company’s 50-day moving average is $87.58. The company has a market capitalization of $309.43 million, a P/E ratio of 20.24 and a beta of 0.25. Utah Medical Products has a 12-month low of $81.01 and a 12-month high of $133.87.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They issued a “Strong Buy” rating on the stock.

A number of large investors have recently increased or reduced their stakes in UTMD. JPMorgan Chase & Co. increased its stake in Utah Medical Products shares by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. Barclays PLC increased its holdings of Utah Medical Products shares by 196.3% in the fourth quarter. Barclays PLC now owns 4,157 shares of the medical device supplier worth $415,000 after buying an additional 2,754 shares in the last quarter. BlackRock Inc. increased its holdings of Utah Medical Products shares by 0.3% in the fourth quarter. BlackRock Inc. now owns 217,007 shares of the medical device supplier worth $21,700,000 after purchasing an additional 748 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Utah Medical Products stock in Q4 for approximately $233,000. Finally, State Street Corp increased its stake in Utah Medical Products shares by 2.4% in the 4th quarter. State Street Corp now owns 68,934 shares of the medical device supplier worth $6,893,000 after buying an additional 1,599 shares in the last quarter. 71.44% of the shares are currently held by institutional investors.

About Utah Medical Products (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Read more

Dividend history for Utah Medical Products (NASDAQ:UTMD)



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

Joan J. Dean

The author Joan J. Dean